Bottle Label 5 mg (71610 0722 45)
Amlodipine Besylate Tablet
Product Images NDC 71610-722
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena Pharma Solutions (TN)
Fig1 (Fig1)
Fig2 (Fig2)
This text provides information from a study involving 1318 ARPatients. The age distribution shows that 985 patients are under the age of 65, while 333 patients are 65 or older. There are 984 male patients and 334 female patients in the study. The baseline sitting systolic blood pressure (SBP) is categorized as either <=Mean or >=Mean, with 695 patients falling into the <=Mean category and 618 patients falling into the >=Mean category. The presence of baseline vessel disease is divided into single and multiple cases, with 0 patients having single vessel disease and 1315 patients having multiple vessel disease. The presence of vessels with stenosis is also reported, with 350 patients having at least one vessel with > 60% stenosis and 485 patients having no vessels with > 60% stenosis. The study also includes data on the use of amlodipine and placebo, and information on stent placement in different patient groups. The hazard ratio is mentioned as well. The mean sitting baseline SBP is reported as 129 mmHg.*
Structure (Ima)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
